Gilead Sciences Inc (GILD, Financial) is set to release its Q2 2024 earnings on Aug 8, 2024. The consensus estimate for Q2 2024 revenue is $6,718.63 million, and the earnings are expected to come in at $1.12 per share. The full year 2024's revenue is expected to be $27.58 billion and the earnings are expected to be $0.41 per share. More detailed estimate data can be found on the Estimates page.
Gilead Sciences Inc (GILD, Financial) Estimates Trends
The revenue estimates for Gilead Sciences Inc (GILD) have declined from $27.61 billion to $27.58 billion for the full year 2024, and from $27.96 billion to $27.91 billion for 2025 over the past 90 days. Earnings estimates for Gilead Sciences Inc (GILD) have declined from $0.45 per share to $0.41 per share for the full year 2024, and from $5.24 per share to $5.22 per share for 2025 over the past 90 days.
Gilead Sciences Inc (GILD, Financial) Reported History
In the previous quarter of March 31, 2024, Gilead Sciences Inc's (GILD) actual revenue was $6.69 billion, which beat analysts' revenue expectations of $6.34 billion by 5.45%. Gilead Sciences Inc's (GILD) actual earnings were -$3.34 per share, which missed analysts' earnings expectations of -$1.79 per share by -86.91%. After releasing the results, Gilead Sciences Inc (GILD) was up by 0.23% in one day.
Gilead Sciences Inc (GILD, Financial) 12 Month Price Targets
Based on the one-year price targets offered by 26 analysts, the average target price for Gilead Sciences Inc (GILD) is $81.02 with a high estimate of $119 and a low estimate of $67. The average target implies an upside of 9.23% from the current price of $74.18.
Based on GuruFocus estimates, the estimated GF Value for Gilead Sciences Inc (GILD, Financial) in one year is $75.89, suggesting an upside of 2.31% from the current price of $74.18.
Based on the consensus recommendation from 32 brokerage firms, Gilead Sciences Inc's (GILD, Financial) average brokerage recommendation is currently 2.5, indicating an "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
